TABLE 1.
Patient characteristics
| Characteristic | |
|---|---|
| Median age (years) | 67 (range 51–80) |
| Sex (N) | |
| Male | 10 |
| Female | 5 |
| Prior lines of therapy in metastatic setting (N) | |
| None | 1 |
| 1 line | 9 |
| 2 lines | 5 |
| Number of patients who received prior checkpoint inhibitor | 10 |
| Histology | |
| Adenocarcinoma | 10 |
| Squamous undifferentiated cell carcinoma | 3 |
| Undifferentiated large cell carcinoma | 1 |
| Large cell neuroendocrine carcinoma | 1 |
| Number of patients by site | |
| Avera Cancer Institute, South Dakota, USA | 5 |
| VHIO, Barcelona, Spain | 3 |
| Chaim Sheba Medical Center, Tel Hashomer, Israel | 3 |
| University of California San Diego Moores Cancer Center, CA, USA | 2 |
| Centre Hospitalier du Luxembourg, Luxembourg | 2 |